National Lab Briefs

Brookhaven National Lab’s High Flux Beam Reactor got a major boost last month when a Department of Energy committee recommended that a proposed $20 million upgrade of the reactor be included in next year’s budget. A DOE official says that the project “has a good shot” of making it into the president’s 1990 budget request, which will be submitted next January. The upgrade will allow the 23-year-old reactor to remain the nation’s primary neutron source for th

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Brookhaven National Lab’s High Flux Beam Reactor got a major boost last month when a Department of Energy committee recommended that a proposed $20 million upgrade of the reactor be included in next year’s budget. A DOE official says that the project “has a good shot” of making it into the president’s 1990 budget request, which will be submitted next January. The upgrade will allow the 23-year-old reactor to remain the nation’s primary neutron source for the next dozen or so years, according to Martin Blume, the lab’s deputy director. Blume is already preparing arguments to overcome the reactor’s next hurdle, a current congressional embargo on new DOE construction projects. “Even if that restriction is extended through 1990,” Blume says, “we would argue that this is not a new start but rather an improvement to an existing facility.”

A new supercomputer will allow NASA scientists at the Jet Propulsion Lab ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies